416 related articles for article (PubMed ID: 15944305)
1. Mechanisms of mucosal and parenteral tuberculosis vaccinations: adenoviral-based mucosal immunization preferentially elicits sustained accumulation of immune protective CD4 and CD8 T cells within the airway lumen.
Santosuosso M; Zhang X; McCormick S; Wang J; Hitt M; Xing Z
J Immunol; 2005 Jun; 174(12):7986-94. PubMed ID: 15944305
[TBL] [Abstract][Full Text] [Related]
2. Single mucosal, but not parenteral, immunization with recombinant adenoviral-based vaccine provides potent protection from pulmonary tuberculosis.
Wang J; Thorson L; Stokes RW; Santosuosso M; Huygen K; Zganiacz A; Hitt M; Xing Z
J Immunol; 2004 Nov; 173(10):6357-65. PubMed ID: 15528375
[TBL] [Abstract][Full Text] [Related]
3. Intranasal boosting with an adenovirus-vectored vaccine markedly enhances protection by parenteral Mycobacterium bovis BCG immunization against pulmonary tuberculosis.
Santosuosso M; McCormick S; Zhang X; Zganiacz A; Xing Z
Infect Immun; 2006 Aug; 74(8):4634-43. PubMed ID: 16861651
[TBL] [Abstract][Full Text] [Related]
4. Development of cell-based tuberculosis vaccines: genetically modified dendritic cell vaccine is a much more potent activator of CD4 and CD8 T cells than peptide- or protein-loaded counterparts.
Malowany JI; McCormick S; Santosuosso M; Zhang X; Aoki N; Ngai P; Wang J; Leitch J; Bramson J; Wan Y; Xing Z
Mol Ther; 2006 Apr; 13(4):766-75. PubMed ID: 16343993
[TBL] [Abstract][Full Text] [Related]
5. Murine airway luminal antituberculosis memory CD8 T cells by mucosal immunization are maintained via antigen-driven in situ proliferation, independent of peripheral T cell recruitment.
Jeyanathan M; Mu J; McCormick S; Damjanovic D; Small CL; Shaler CR; Kugathasan K; Xing Z
Am J Respir Crit Care Med; 2010 Apr; 181(8):862-72. PubMed ID: 20019338
[TBL] [Abstract][Full Text] [Related]
6. Mucosal luminal manipulation of T cell geography switches on protective efficacy by otherwise ineffective parenteral genetic immunization.
Santosuosso M; McCormick S; Roediger E; Zhang X; Zganiacz A; Lichty BD; Xing Z
J Immunol; 2007 Feb; 178(4):2387-95. PubMed ID: 17277145
[TBL] [Abstract][Full Text] [Related]
7. Role of B Cells in Mucosal Vaccine-Induced Protective CD8+ T Cell Immunity against Pulmonary Tuberculosis.
Khera AK; Afkhami S; Lai R; Jeyanathan M; Zganiacz A; Mandur T; Hammill J; Damjanovic D; Xing Z
J Immunol; 2015 Sep; 195(6):2900-7. PubMed ID: 26268652
[TBL] [Abstract][Full Text] [Related]
8. Protective immune responses to a recombinant adenovirus type 35 tuberculosis vaccine in two mouse strains: CD4 and CD8 T-cell epitope mapping and role of gamma interferon.
Radosevic K; Wieland CW; Rodriguez A; Weverling GJ; Mintardjo R; Gillissen G; Vogels R; Skeiky YA; Hone DM; Sadoff JC; van der Poll T; Havenga M; Goudsmit J
Infect Immun; 2007 Aug; 75(8):4105-15. PubMed ID: 17526747
[TBL] [Abstract][Full Text] [Related]
9. Gene-based neonatal immune priming potentiates a mucosal adenoviral vaccine encoding mycobacterial Ag85B.
Dai G; Rady HF; Huang W; Shellito JE; Mason C; Ramsay AJ
Vaccine; 2016 Dec; 34(50):6267-6275. PubMed ID: 27823900
[TBL] [Abstract][Full Text] [Related]
10. Enhanced immunogenicity and protective efficacy against Mycobacterium tuberculosis of bacille Calmette-Guérin vaccine using mucosal administration and boosting with a recombinant modified vaccinia virus Ankara.
Goonetilleke NP; McShane H; Hannan CM; Anderson RJ; Brookes RH; Hill AV
J Immunol; 2003 Aug; 171(3):1602-9. PubMed ID: 12874255
[TBL] [Abstract][Full Text] [Related]
11. Effects of the fusion design and immunization route on the immunogenicity of Ag85A-Mtb32 in adenoviral vectored tuberculosis vaccine.
Zhang Y; Feng L; Li L; Wang D; Li C; Sun C; Li P; Zheng X; Liu Y; Yang W; Niu X; Zhong N; Chen L
Hum Vaccin Immunother; 2015; 11(7):1803-13. PubMed ID: 26076321
[TBL] [Abstract][Full Text] [Related]
12. CXCR6 is a marker for protective antigen-specific cells in the lungs after intranasal immunization against Mycobacterium tuberculosis.
Lee LN; Ronan EO; de Lara C; Franken KL; Ottenhoff TH; Tchilian EZ; Beverley PC
Infect Immun; 2011 Aug; 79(8):3328-37. PubMed ID: 21628524
[TBL] [Abstract][Full Text] [Related]
13. Airway delivery of soluble mycobacterial antigens restores protective mucosal immunity by single intramuscular plasmid DNA tuberculosis vaccination: role of proinflammatory signals in the lung.
Jeyanathan M; Mu J; Kugathasan K; Zhang X; Damjanovic D; Small C; Divangahi M; Petrof BJ; Hogaboam CM; Xing Z
J Immunol; 2008 Oct; 181(8):5618-26. PubMed ID: 18832720
[TBL] [Abstract][Full Text] [Related]
14. Immunization with a bivalent adenovirus-vectored tuberculosis vaccine provides markedly improved protection over its monovalent counterpart against pulmonary tuberculosis.
Mu J; Jeyanathan M; Small CL; Zhang X; Roediger E; Feng X; Chong D; Gauldie J; Xing Z
Mol Ther; 2009 Jun; 17(6):1093-100. PubMed ID: 19319120
[TBL] [Abstract][Full Text] [Related]
15. Using a prime and pull approach, lentivector vaccines expressing Ag85A induce immunogenicity but fail to induce protection against Mycobacterium bovis bacillus Calmette-Guérin challenge in mice.
Britton G; MacDonald DC; Brown JS; Collins MK; Goodman AL
Immunology; 2015 Oct; 146(2):264-70. PubMed ID: 26095282
[TBL] [Abstract][Full Text] [Related]
16. Sequential pulmonary immunization with heterologous recombinant influenza A virus tuberculosis vaccines protects against murine M. tuberculosis infection.
Muflihah H; Flórido M; Lin LCW; Xia Y; Triccas JA; Stambas J; Britton WJ
Vaccine; 2018 Apr; 36(18):2462-2470. PubMed ID: 29602704
[TBL] [Abstract][Full Text] [Related]
17. Immunization with different formulations of Mycobacterium tuberculosis antigen 85A induces immune responses with different specificity and protective efficacy.
Tchilian E; Ahuja D; Hey A; Jiang S; Beverley P
Vaccine; 2013 Sep; 31(41):4624-31. PubMed ID: 23896422
[TBL] [Abstract][Full Text] [Related]
18. [Immunoprophylaxis of recombinant Mycobacterium vaccae secreted MPT64 of Mycobacterium tuberculosis].
Bai YL; Xue Y; Wang LM; Fan AL; Zhang W; Kang J; He JJ; Xu ZK
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2009 Mar; 25(3):211-4. PubMed ID: 19257983
[TBL] [Abstract][Full Text] [Related]
19. Respiratory mucosal immunization with adenovirus gene transfer vector induces helper CD4 T cell-independent protective immunity.
Mu J; Jeyanathan M; Shaler CR; Horvath C; Damjanovic D; Zganiacz A; Kugathasan K; McCormick S; Xing Z
J Gene Med; 2010 Aug; 12(8):693-704. PubMed ID: 20694950
[TBL] [Abstract][Full Text] [Related]
20. Subcutaneous administration of modified vaccinia virus Ankara expressing an Ag85B-ESAT6 fusion protein, but not an adenovirus-based vaccine, protects mice against intravenous challenge with Mycobacterium tuberculosis.
You Q; Jiang C; Wu Y; Yu X; Chen Y; Zhang X; Wei W; Wang Y; Tang Z; Jiang D; Wu Y; Wang C; Meng X; Zhao X; Kong W
Scand J Immunol; 2012 Jan; 75(1):77-84. PubMed ID: 21916923
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
